Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other S&P 500 stocks. 2024 was a memorable year for the broad market index ...

Regeneron Pharmaceuticals ... effects for these next-generation T-cell engaging therapies and potentially address tumour types historically unresponsive to immunotherapy. Dr John Lin, senior ...

Regeneron has signed a collaboration deal potentially worth $1 billion with RNAi experts Alnylam Pharmaceuticals, to develop and commercialise drugs targeting eye, central nervous system (CNS ...

This summer, I completed an internship in the department Therapeutic Antibodies engaging in Pre-Clinical Antibodies and Assay Development at Regeneron Pharmaceuticals Inc. What an enriching ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ETH Zurich's second campus, built from 1961, is located in the north of the city in a rural setting on the Hönggerberg. ETH Zurich's space requirements have been increasing for years and are ...

For those familiar with the UNLV campus today, also missing just 25 years ago were Greenspun ... During his fifth State of the University Address, UNLV President Keith E. Whitfield asked a packed ...